Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
MAPK/ERK Pathway
MAPK/ERK Pathway
/
ERK
ERK
ERK
Products (27)
EGFR Inhibitor STX-721
CAS No.:
2765525-82-2
Elironrasib
CAS No.:
2641998-63-0
RMC-4998
CAS No.:
2642037-07-6
Lazertinib
CAS No.:
1903008-80-9
Selumetinib
CAS No.:
606143-52-6
Paluratide
CAS No.:
2676177-63-0
Deltonin
CAS No.:
55659-75-1
Daporinad
CAS No.:
658084-64-1
Ezatiostat
CAS No.:
168682-53-9
Ulixertinib
CAS No.:
869886-67-9
Xanthocillin X
CAS No.:
580-74-5
N-Benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide
CAS No.:
353250-09-6
Temuterkib
CAS No.:
1951483-29-6
Ravoxertinib
CAS No.:
1453848-26-4
Mek-IN-6
CAS No.:
2845151-86-0
338JH2SY4A
CAS No.:
1412453-70-3
Ko-947
CAS No.:
1695533-89-1
Mk-8353
CAS No.:
1184173-73-6
Lut-014
CAS No.:
2274819-46-2
Rineterkib
CAS No.:
1715025-32-3
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact